Trial intelligence / Profile preview

Administration study of testosterone undecanoate in healthy adult males

jRCT1071210006Completed

Sponsor
LSI Medience Corporation
Start
Feb 2021
Countries
2
01

Overview

Open-label, single-arm trial of testosterone undecanoate, sponsored by LSI Medience Corporation. Primary endpoint: Detection period of unchanged testosterone undecanoate and metabolites. Started Feb 2021; status: completed.

02

Drugs

testosterone undecanoate

Beyond the preview

Go deeper on jRCT1071210006.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1071210006.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call